State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a change in its holdings of Novavax Inc. common stock. According to the filing, State Street Corporation now has shared voting power over 5,597,236 shares and shared dispositive power over 6,066,179 shares of Novavax Inc. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of Novavax's class of common stock. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose or effect of changing or...Show More

State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a change in its holdings of Novavax Inc. common stock. According to the filing, State Street Corporation now has shared voting power over 5,597,236 shares and shared dispositive power over 6,066,179 shares of Novavax Inc. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of Novavax's class of common stock. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose or effect of changing or influencing the control of Novavax, nor in connection with any transaction having such purpose or effect. The subsidiaries of State Street Corporation listed in the filing, all classified as investment advisors (IA), include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, and State Street Global Advisors, Australia, Limited.